DNMT1 and Alzheimer disease: They also observed that nuclear immunoreactivity for the DNA methyltransferase (DNMT1) and for six different components of the MeCP1/MBD2 methylation complex was significantly reduced in the entorhinal cortex of AD subjects than in controls.